Advertisement
Singapore markets closed

  • Straits Times Index

    3,292.93
    -3.96 (-0.12%)
     

  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     

  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • Bitcoin USD

    63,295.48
    +446.17 (+0.71%)
     

  • CMC Crypto 200

    1,313.20
    +36.22 (+2.84%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • Dow

    38,675.68
    +450.02 (+1.18%)
     

  • Nasdaq

    16,156.33
    +315.37 (+1.99%)
     

  • Gold

    2,310.10
    +0.50 (+0.02%)
     

  • Crude Oil

    77.99
    -0.96 (-1.22%)
     

  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     

  • FTSE Bursa Malaysia

    1,589.59
    +9.29 (+0.59%)
     

  • Jakarta Composite Index

    7,134.72
    +17.30 (+0.24%)
     

  • PSE Index

    6,615.55
    -31.00 (-0.47%)
     

Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher

Zacks Equity Research

Sucampo Pharmaceuticals, Inc. (SCMP) was a big mover last session with its shares rising over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained nearly 45% in the past one-month time frame.

This biopharmaceutical company has seen two positive estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.

Sucampo currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Investors interested in the Med-Drugs industry may also consider stocks like Lannett Company, Inc. (LCI), Cempra, Inc. (CEMP) and Shire plc (SHPG). While Lannett Company sports a Zacks Rank #1, Cempra and Shire hold a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




SUCAMPO PHARMACEUTICALS CL A (SCMP): Free Stock Analysis Report

CEMPRA INC (CEMP): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

SHIRE PLC ADS (SHPG): Free Stock Analysis Report


Zacks Investment Research